Prior psychiatric treatment and the development of breast cancer.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Psychopharmacology bulletin

• Publication date

  1978-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/ARCHPSYC.1978.01770310104009PMID 625531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma prolactin and its relationship to risk factors in human breast cancer

  1976cited by this paper
• Prolactin and breast carcinoma.

  1975cited by this paper
• Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women.

  1974cited by this paper
• The Effects of Phenothiazines on Endocrine Function: I

  1974cited by this paper
• Reserpine use in relation to breast cancer.

  1974cited by this paper
• Functional evaluation of prolactin secretion: a guide to therapy.

  1972cited by this paper
• Clinical use of psychotherapeutic drugs.

  1970cited by this paper
• Investigation of clinical outcome in a doctor's choice treatment setting.

  1969cited by this paper
• CHLORPROMAZINE AND ENDOCRINE FUNCTION

  1967cited by this paper
• Mortality in state mental hospitals of Michigan, 1950-54.

  1958cited by this paper

• Post-diagnostic antipsychotic use and breast cancer mortality: a population based cohort study

  2020cites this paper
• Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study

  2020cites this paper
• Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions

  2018cites this paper
• The use of atypical antipsychotics and the risk of breast cancer

  2011cites this paper
• The Effect Of Chronic Use Of Antipsychotics On The Bone, Breast and Cervix -

  2011cites this paper
• Duty to care.

  2009cites this paper
• Clinical Psychopharmacology and Other Somatic Therapies

  2008cites this paper
• 34 Psychopharmacology and Other Somatic Therapies

  2008cites this paper
• Cancer risk among users of neuroleptic medication: a population-based cohort study

  2006influential citation
• Occurrence of Cancer Among People With Mental Health Claims in an Insured Population

  2004cites this paper
• Schizophrenia and the risk for breast cancer.

  2003cites this paper
• The Effects of Atypical Antipsychotics on Serum Prolactin Levels

  2002cites this paper
• Dopamine antagonists and the development of breast cancer.

  2002cites this paper
• Psychotropic medication use and risk of hormone-related cancers: the New York University Women's Health Study.

  2000cites this paper
• Neuroleptic-induced hyperprolactinemia.

  1999cites this paper
• THE SIDE-EFFECTS OF ANTIPSYCHOTIC DRUGS. II. EFFECTS ON OTHER PHYSIOLOGICAL SYSTEMS

  1993cites this paper
• The occurence of cancer in first admitted schizophrenic patients

  1992cites this paper
• Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients

  1987cites this paper
• Psychiatric aspects of oncology: a review of recent research.

  1983cites this paper
• Neuroleptika: Grundlagen und Therapie

  1983cites this paper
• Psychiatric aspects of cancer.

  1981cites this paper
• Quantitative Determination of Immunoglobulins in CSF and Plasma of Chronic Schizophrenic Patients

  1981cites this paper
• Cancer and mental illness.

  1981cites this paper
• Breast cancer in hospitalized psychiatric patients.

  1981cites this paper
• THE INFLUENCE OF NEUROLEPTIC DRUGS ON PROLACTIN SECRETION IN CHILDREN

  1980cites this paper
• Adverse effects in maintenance treatment: practical and theoretical considerations.

  1979cites this paper
• The major tranquillizers

  1979cites this paper
• Breast Cancer and Treatment With Neuroleptics-Reply

  1979cites this paper
• Breast cancer at a psychiatric hospital before and after the introduction of neuroleptic agents.

  1978cites this paper
• Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue.

  1978cites this paper